BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32957649)

  • 1. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
    Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
    Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
    Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration.
    Jia Y; Zhang Q; Liu Z; Pan P; Jia Y; Zhu P; Jiao Y; Kang G; Ma X
    Toxicology; 2022 Mar; 469():153120. PubMed ID: 35131329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLEK2 mediates metastasis and invasion via α5-nAChR activation in nicotine-induced lung adenocarcinoma.
    Li Q; Li J; Wang J; Wang J; Lu T; Jia Y; Sun H; Ma X
    Mol Carcinog; 2024 Feb; 63(2):253-265. PubMed ID: 37921560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
    Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
    J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling.
    Pillai S; Rizwani W; Li X; Rawal B; Nair S; Schell MJ; Bepler G; Haura E; Coppola D; Chellappan S
    Mol Cell Biol; 2011 Jul; 31(14):3052-67. PubMed ID: 21606196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation.
    Zhang Y; Jia Y; Li P; Li H; Xiao D; Wang Y; Ma X
    J Genet Genomics; 2017 Jul; 44(7):355-362. PubMed ID: 28750889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine induces resistance to epidermal growth factor receptor tyrosine kinase inhibitor by α1 nicotinic acetylcholine receptor-mediated activation in PC9 cells.
    Wang S; Takayama K; Tanaka K; Takeshita M; Nakagaki N; Ijichi K; Li H; Nakanishi Y
    J Thorac Oncol; 2013 Jun; 8(6):719-25. PubMed ID: 23625155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway.
    Brown KC; Perry HE; Lau JK; Jones DV; Pulliam JF; Thornhill BA; Crabtree CM; Luo H; Chen YC; Dasgupta P
    J Biol Chem; 2013 Nov; 288(46):33049-59. PubMed ID: 24089524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α5-nAChR modulates nicotine-induced cell migration and invasion in A549 lung cancer cells.
    Sun H; Ma X
    Exp Toxicol Pathol; 2015 Sep; 67(9):477-82. PubMed ID: 26205096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α5-nAChR and survivin: Two potential biological targets in lung adenocarcinoma.
    Zhang Y; Sun Y; Jia Y; Zhang Q; Zhu P; Ma X
    J Cell Physiol; 2021 Mar; 236(3):1787-1797. PubMed ID: 33196129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma.
    Zhuang L; Shou T; Li K; Gao CL; Duan LC; Fang LZ; Zhang QY; Chen ZN; Zhang C; Yang ST; Li GF
    J Cell Mol Med; 2017 Nov; 21(11):2852-2862. PubMed ID: 28653805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model.
    Li H; Wang S; Takayama K; Harada T; Okamoto I; Iwama E; Fujii A; Ota K; Hidaka N; Kawano Y; Nakanishi Y
    Lung Cancer; 2015 Apr; 88(1):1-8. PubMed ID: 25670150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumoral activity of the human-specific duplicated form of α7-nicotinic receptor subunit in tobacco-induced lung cancer progression.
    Cedillo JL; Bordas A; Arnalich F; Esteban-Rodríguez I; Martín-Sánchez C; Extremera M; Atienza G; Rios JJ; Arribas RL; Montiel C
    Lung Cancer; 2019 Feb; 128():134-144. PubMed ID: 30642446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1α and VEGF expression in non-small cell lung cancer.
    Ma X; Jia Y; Zu S; Li R; Jia Y; Zhao Y; Xiao D; Dang N; Wang Y
    Toxicol Appl Pharmacol; 2014 Jul; 278(2):172-9. PubMed ID: 24793809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α5-nAChR/ADAM10 signaling mediates nicotine-related cutaneous melanoma progression via STAT3 activation.
    Li X; Meng X; Fan H; Wang Y; Jia Y; Jiao J; Ma X
    Arch Dermatol Res; 2024 May; 316(6):269. PubMed ID: 38795191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine-Mediated Regulation of Nicotinic Acetylcholine Receptors in Non-Small Cell Lung Adenocarcinoma by E2F1 and STAT1 Transcription Factors.
    Schaal C; Chellappan S
    PLoS One; 2016; 11(5):e0156451. PubMed ID: 27228072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion.
    Zhu P; Kang G; Jiao Y; Gui C; Fan H; Li X; Jia Y; Zhang L; Ma X
    Hum Cell; 2022 Jul; 35(4):1207-1218. PubMed ID: 35593989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.